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1 Introduction 
Mycobacterium tuberculosis, the causative agent associated with the trans-
mission of tuberculosis, was discovered by Robert Koch in 1882. Bacilli are 
spread in the air when infectious individuals sneeze, cough, speak or sing 
(American Thoracic Society, CDC, 1990). A susceptible individual may be-
come infected with TB if he or she inhales bacilli from the air. The particles 
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containing Mycobacterium tuberculosis are so small that normal air currents 
not only keep them airborne but also transport them throughout rooms or 
buildings (Wells, 1995). Individuals who regularly share space with those 
with active TB (the infectious stage of the disease) naturally have a higher 
risk of becoming infected than those who do not. Infections occur when 
susceptible persons inhale droplet nuclei containing Mycobacterium tubercu-
losis. The bacilli become established in the alveoli of the lungs from where 
they spread throughout the body. Hosts' immune response usually limits 
further bacilli multiplication and the spread that naturally follows initial in-
fections. Only a small proportion of newly infected persons (usually less 
than 1%) develops active infections, that is, only a tiny proportion of those 
infected progresses rapidly towards active-TB. Between 5% and 10% of in-
fecteds eventually develop active-TB but typically, they do it rather slowly. 
Most infected individuals remain as latently-infected carriers for their entire 
lifes. In general the distribution of progression times is skewed. The aver-
age length of the latent period (carrier at non-infectious stage) ranges from 
months to decades but the risk of progression, towards active-TB, increases 
markedly in the presence of co-infections that debilitate the immune system. 
In other words, the presence of co-infections alters the shape of the distri-
bution of progression times. Persons with HIV co-infections progress faster 
towards the active (infectious) TB state than those without them (Selwyn et 
al., 1989). However, impact from co-infections may be temporal if effective 
approaches are used against them. 
Effective and widespread treatment for active and latently infected indi-
viduals has been available for about five decades. Streptomycin, an antibiotic, 
first discovered at Rutgers University in 1943, is still used but with pyraz-
inamide. Currently Isoniazid and Rifampin are most effective in the fight 
against M. tuberculosis. The widespread introduction of antibiotics reduced 
mortality by 70% from 1945 to 1955 in the U.S. but major reductions on 
TB mortality rates had already been achieved before their introduction (see 
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Aparicio et al., 2000; Dubas and Dubas, 1952; Lowell et al., 1969). Latent 
TB can be handled with a single dmg Isoniazid but treatment is effective 
only if applied for at least six months. Active cases must be treated for nine 
months with multiple drugs (Isoniazid, Rifampin, Pyrazinamide ) and com-
plex regimens. Treatment in the U.S. covers over 95% of the cases (WHO, 
2000b) despite its high cost. The expenses associated with treatment pro-
grams are so high that their effective implementation are pretty much out of 
reach in most developing nations. Antibiotic resistant strains may be easily 
generated if treatment is not completed and the consequences may be serious 
for such individuals (see Castilla-Chavez and Feng, 1997). Lack of treatment 
compliance has not only local but also global serious consequences that are 
not difficult to imagine in today's society (see Kalata, 1995). 
In 1989, CDC and ACET (Advisory Council for the Elimination of Tu-
berculosis) set long term national goals for TB control that included specific 
national targets (CDC, 1989). CDC's goal was to reduce the case rate of TB 
to less than 3.5/100,000 by 2000 and to about 1/1,000,000 by 2010. Data sug-
gest that these targets were optimistic. In this paper, we show that targeting 
a higher proportion of latently-infected individuals increases the likelihood 
that CDC's target may be reached. We illustrate the effect of treating a 
higher proportion of latently-infected individuals on CDC's target and show 
that meeting CDC's goal by 2020 is actually possible. 
Our paper is organized as follows: Section 2 introduces the basic model 
structure for the study of the dynamics of TB transmission; the asymptotic 
behavior of the model of Section 2 is analyzed in Section 3; a function that 
captures the impact of HIV /AIDS on TB progression is introduced in Section 
4; parameter values and parameter ranges are introduced and discussed in 
Section 5; Section 6 collects the results of simulations using estimated param-
eters and collects our conclusions; finally the Appendix includes two tables 
with a forecast of active TB cases by 2050 and the proof of the theorem on 
the asymptotic dynamics of our model. 
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2 Model structure 
Tuberculosis, a slowly progressing disease, was one of the biggest contributors 
to human mortality in the past. TB's world prevalence of asymptomatics is 
huge (about one out of three persons may be infected with TB) but progres-
sion to active TB has slowed down (Aparicio et al., 2000). In order to mimic 
the dynamics of TB over the past five decades, our model includes the U.S. 
population's demography. In addition, individuals are classified according 
to their TB epidemiological status: susceptible (S), latent/exposed (L) and 
(actively) infectious (I). We do not keep track of specific co-infections in-
cluding HIV co-infections to keep the model as simple as possible. In fact, 
we do it in a practical way since our focus here is on TB control. Dynamical 
models for the transmission dynamics of tuberculosis have been developed 
in the recent past (Castilla-Chavez, 1997, 1998; Blower, 1995 and references 
therein). A similar approach leads to the following model: 
dS di = F(N)- B(S, I, N) + r 2L + r 1I, 
dL 
dt = B(S, I, N)- (p, + k + r 2 )L, 
di 
dt = kL- (p, + d + r1)I, 
(1) 
(2) 
(3) 
where F(N) represents the recruitment rate as a function of total population 
size N; B(N, I, S) denotes the incidence rate per unit time; ri(i = 1, 2) denote 
treatment rates for actively and latently-infected individuals, respectively. 
The dynamics of the total population size N(t) = S(t)+L(t)+I(t) is governed 
by the equation 
dN = F(N)- di 
dt ' (4) 
where d is the tuberculosis induced death rate, a very small rate when com-
pared to the "natural" death rate (mortality rate due to all other causes). 
F(N) will be assumed to be either a linear (exponential growth) or a non-
linear bounded function. This assumption covers most observed popula-
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tion growth patterns on the time scale of TB epidemics (Song et al., 2001). 
B(N, I, S) will simply be taken as f3Stt (random mixing). 
In modeling "recent" (last five decades) tuberculosis transmission in the 
U.S. it is reasonable to disregard the impact of TB-induced mortality, that is, 
taking d = 0 is quite reasonable. Hence, the dynamics of TB in the U.S. over 
the past few decades can be reasonably modeled by a system where demog-
raphy and epidemiology are uncoupled. Or equivalently, it can be modeled 
via a non-autonomous system since N(t) can be "explicitly" computed from 
the demographic equation~~ = F(N). Consequently, Equations (2) and (3) 
are enough to describe the transmission dynamics of tuberculosis, that is, 
our system reduces to the following non-autonomous system: 
dL ( ) I dt = {3 N(t) - L- I N(t) - (J.t(t) + k + r2 )L, (5) 
di 
dt = kL- (J.t(t) + d(t) + r1 )I, (6) 
where N(t), now assumed independent of the disease, is a known 'external' 
input to the epidemiological model. The values of N(t) are inputted using 
published U.S. demographic data. The transmission rate,{3, is assumed con-
stant; k, TB's activation rate, is also assumed to be constant; ri (i = 1, 2), 
the treatment rates defined before, are also assumed to be constant. J.t(t) 
and d(t) are, in general, functions of time (see Aparicio et al., 2000). 
Age-structure and immigration (critical factors on TB persistence in the 
U.S.) can easily be incorporated into the modeling framework. However, data 
needs required by structured models can be huge and hence nearly impossible 
to meet. 
If n(t, a) denotes the age distribution of the population at timet per unit 
time then the corresponding age-structured demographic model is 
an an 
at + aa = -J.t(t, a)+ m(t, a), (7) 
n(t, 0) = B(t)- J.to(t), (8) 
n(O, a)= n0 (a), (9) 
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where J.t(t, a) is the time-dependent age-specific death rate per unit time; 
m(t, a) denotes the age-specific net immigration rate per unit time (for the 
U.S., m(t, a) would be assumed to be positive for all ages); n0 (a) denotes 
the initial distribution of the total population; n(t, 0) denotes the net birth 
rate, which equals B(t), the total birth rate, minus J.to(t), the death rate of 
newborns. The total population size is N(t) = J000 n(t, a)da. System (5-9) 
is a mixture of demography and epidemiology that includes immigration. A 
study of the solutions n(t, a) in System (7-9) can be found in (Iannelli, 1995 
or Webb, 1985). Here, it is assumed that N(t) = f000 n(t, a)da, J.t(t) and d(t) 
are bounded from below and from above. These assumptions guarantee that 
all solutions of the non-autonomous System (5-6) are bounded and nonneg-
ative. Age-structure could also be incorporated in the epidemiology. We do 
not consider population structure explicitly in either the demography or the 
epidemiology because our general objectives fortunately can be met with the 
simpler system that requires less (and available) data. 
3 Asymptotic behavior of solutions 
An asymptotic analysis of Model (5-6) is carried out in the Appendix but 
the results are discussed in this section since they play a role in the param-
eterization of the model. The analysis helps establish a criterion for disease 
persistence, that is, a threshold condition, that must be met by our param-
eterized model. Such criterion also helps narrow down parameter ranges. 
Hence, the long term behavior of our system is determined by the asymp-
totic property of the functions N(t), M(t) and d(t). The following theorem 
characterizes such behavior: 
Theorem. Assume liminfJ..t(t) = J.t001 liminfd(t) = d00 , and 
t-+oo t-+oo 
lim supj.t(t) = J.t00 , lim supd(t) = d00 • 
t-+oo t-+oo 
1. If Roo= (k+ k + ) ( +~ + ) ::; 1 then limL(t) = liml(t) = 0. /1-oo r2 /1-oo oo r1 t-+oo t-+OO 
6 
2. If R 00 = ( k+J"!,+r2 ) C=+:=+rJ ~ 1 then li~~pL(t) > 0, and 
limsupl(t) > 0. 
t->oo 
When p(t) = p and d(t) = d (both constant) then R00 =Roo= R 0 gives 
the classical basic reproductive number, that is, 
R _ /3 ( 1 ) ( k ) 
o- p+d+~ k+p+~ 
where f3 is the effective contact rate; q +~+d is the effective infectious period; 
r2+~+k is the proportion of latently-infected individuals who make it to the 
active stage. In other words, R 0 gives the average number of secondary in-
fectious generated by a typical actively infected individual in a population 
of mostly susceptibles that is, in a population of susceptibles at a demo-
graphic steady state (autonomous system). This theorem provides a sharp 
classification for the two important biological states: disease elimination or 
persistence for non-autonomous systems. These thresholds help verify the 
reasonableness of published parameters. They are also helpful in the selec-
tion of reasonable ranges of unknown parameters. Our model generalizes the 
results established for related autonomous systems by Feng et al.(2001) and 
Song et al. (2001). 
4 Impact of HIV /AIDS 
Few infected individuals developed active tuberculosis since their immune's 
response is usually effective and fast. The immune system of infected individ-
uals produces a thick waxy coat that almost immediately covers tuberculosis 
bacilli. This action prevents its activation. When the immune system of an 
infected person does not function well, for example, when an individual also 
faces a HIV /AIDS co-infection, the coat covering tuberculosis bacilli becomes 
more fragile and, hence it is more likely to break. Consequently, individuals 
with co-infections that enhance immune deficiencies, face a higher risk of 
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developing active TB infections. Hence, whenever a large pool of latently-
infected TB individuals find themselves in the presence of such co-infections, 
the likelihood of an outbreak of active TB in such population increases. 
Studies have shown that 15% of AIDS deaths are due to tuberculosis 
co-infections (WHO, 2000a). The risk of progression to active disease is 
markedly increased for persons with HIV co-infections (Selwyn, et al., 1989). 
We incorporate the effects of AIDS co-infections from a single outbreak into 
our model in a rather simple and indirect way. A time-dependent function 
that enhances TB progression as a function of HIV risk during the time 
period when HIV had the most impact is used to modify the distributions of 
latent periods. Our assumption is based on the fact that HIV /AIDS increased 
tuberculosis incidence (and vice versa) during some identifiable window in 
time. We incorporate such a function in the following way: 
dL ( ) I dt = /3 N(t)- L- I N(t) - (p,(t) + k + r 2 + A(t))L, (10) 
di 
dt = (k + A(t))L- (p,(t) + d(t) + r 1 )I, (11) 
where 
A(t) = . ' { 0 05(t- 1983)1.8e-v't-l983 if 1983 < t 
0 otherwise. 
A(t) models increased progression from latent to active TB beginning in 1983. 
This function has large values around the middle of the 1980's before HIV 
was identified and before any forms of treatment were available in the U.S .. 
It decreases dramatically afterwards (see Figure 1) in a way dictated by our 
desire to fit the data as close as possible. Mathematically, the addition of 
A(t) does not change the asymptotic behavior of tuberculosis in the U.S. 
albeit it changes its quantitative dynamics over a relative short period of 
time. These changes fit observed patterns because A(t) was chosen to make 
them fit. Hence, we have an epidemiological model that fits demographic 
and epidemiological data for the last five decades. AIDS has, naturally, 
delayed CDC's time table for TB "elimination" and our model explicitly 
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Figure 1: Shape of function of A(t) 
takes account of this effect. The fact that there may be recurrent HIV /AIDS 
epidemics in the future that are not synchronized in time is likely to have 
important implications (recent increases in HIV in San Francisco may fit this 
category). Such temporal asynchrony could be modeled by 
dL ( ) I J di = /3 N(t)- L- I N(t) - (Jt(t) + k + r 2 + ~ Aj(t))L, 
J=l 
(12) 
di J 
dt = (k + :?= Aj(t))L- (Jt(t) + d(t) + ri)I, 
J=l 
(13) 
where each function Aj(t) would have a shape similar to that of A(t) but 
with a different support interval. System (5-6) and (12-13) has the asymp-
totic behavior predicted by our theorem in Section 3 but the time to CDC's 
'TB elimination' may be radically changed if asynchronous epidemics are 
supported. 
We observe that our model has only altered the distribution of progression 
times towards active TB due to the impact of a temporal co-infection, that is, 
a co-infection that impacts progression only for a short period of time. The 
growth of HIV co-infections and their strong impact on TB progression in the 
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1980's and 1990's changed the dynamics at least for a short period of time 
(before they return to their 'normal' or 'natural' dynamics). The fact that 
TB prevalence and incidence exhibited a prolonged downward trend before 
HIV implies that the time to meet CDC's target has been delayed by this 
HIV "perturbation". In summary, we have introduced a model that captures 
this phenomenon, that is an agreement with the data, and that incorporates 
demography and epidemiological interactions. It is in the context of this data-
driven model that strategies to meet CDC's target in a reasonable period of 
time are discussed. 
5 Parameter estimation 
The parameter values and the asymptotic behavior of functions, like f.£( t) 
and N(t), determine the time to CDC's 'TB elimination'. We use the United 
States not only to illustrate the likelihood of meeting CDC's criterion but also 
to discuss the implications of future co-infection outbreaks. The selection of 
the required parameters in this setting is therefore difficult but literatures 
provide a reasonable start. 
We use reasonable ranges and averages (from the literature) and use them 
in our extensive simulations. An explicit list of our parameter selection 
sources and assumptions is provided below: 
1. The value of (3 (effective contact rate) is the product of the contact 
rate c and the transmission probability per contact. CDC has used 
an average contact rate of 9 (Etkind, 1993). Other studies have used 
estimates for c of the same order of magnitude (Shrestha-Kuwahara 
and Marks, 1999). Here, we take c to be around 10. 
2. The value for the transmission probability per contact is around 0.2. 
CDC used 0.21 (Etkind, 1993). It is believed that this value has stabi-
lized. It is believed that it has lived in the range of 0.21 to 0.23 since 
1987 (National Tuberculosis Center, 2001). 
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3. The parameter k represents the per capita rate of progression from 
inactive-TB to active-TB. The exact distribution of the latent periods 
is unknown. Available information claims that 10% of inactive tuber-
culosis cases progress to active tuberculosis within 10 years. There is 
evidence that confirms the occurrence of cases 10 years after primary 
infections. Earlier work of Ferebee (1967) assumed that k = 6~5 year- 1 • 
We shall assume that k is around 0.001 
4. Our dynamic model for tuberculosis transmission is given by a system of 
ordinary differential equations whose solution curves are determined by 
initial conditions. There is no way for us to have a reasonable estimate 
of 'initial' levels of latently-infected individuals but it is reasonable to 
assume this number is of the order of 106 in the U.S .. Ferebee (1967) 
assumed that it was 25, 000, 000 in the U.S. in 1967. More information 
on the number of active tuberculosis than inactive cases is available. 
The incidence rate multiplied by the case finding rate gives a rough 
estimate of the initial levels of active tuberculosis. We take 1953 as 
time zero and assume that /(0) ~ 874230 (10 times the number of 
cases in 1953). 
5. Case reporting rates reflect the case finding rates which have a value 
of around 70%. The probability of successful treatment is greater than 
95% in the U.S. (WHO, 2000). To be consistent with the data r 1 
is assumed to take values around 0.65. The finding rate for inactive 
tuberculosis is about 10%. Latent tuberculosis treatment programs 
have a probability of success of about 0.90 in the U.S.. Treatment 
failure is mostly due to a patient's inability to complete treatment. To 
be consistent with the data r2 is assumed to take values around 0.05. 
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6 Results and discussions 
A discrete version of Model (7-9) for the demography was used by Bureau of 
the Census (Hollmann et al., 2000) to fit and project the U.S. demography. 
The model looks like: 
nt(O) = Bt-I,t- J.lt-I,t(O) + mt-I,t(O), 
nt(a) = nt-I(a- 1)- J.lt-I,t(a) + mt-I,t(a), 
where the total population (sum over all ages) is therefore given by 
Nt = Nt-I +Bt-l t - lit-It + Mt-1 t· 
' t"' ' l 
(14) 
(15) 
(16) 
U.S. population projections by the Bureau of Census are available until 2100 
(Census Bureau of U.S., 1999) from Model (14-16). We use the results of 
theses projections to input the N(t) values required in our simulations. Of 
course, appropriate interpolations have to be made since we are using con-
tinuous time models. Data on mortality and TB induced death rates are 
available but only for the last one and half century (this is sufficient for us). 
In the implementation of our simulations, we interpolate from mortality data 
to obtain estimates for J.L(t) and d(t) when t :::; 2000 and when for t > 2000 
we take them as constants by averaging the corresponding data for last 5-10 
years. We conduct a sensitivity analysis to take into account the impact 
of variation on parameters. In some sense, we treat the parameters of the 
model as random variables from appropriate normal distributions. The val-
ues used as predictors of TB cases in the U.S. are the re~mlt of averaging 
5,000 simulation runs. 
Figure 2 shows that for the selected parameter ranges, the progression rate 
function A( t) fits the data very well. That is, the fit successfully captures 
the past history of TB in the U.S.. A value of r 2 = 0.05 says that in the 
past only 5% of latently-infected individuals got treated per unit time. The 
treatment of 100% of active TB cases per unit time (r1 = 1, instead of 0.65) is 
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Figure 2: Left: New case of TB and data (dots). Right: 10% error bound of 
new cases and data 
insufficient to reach CDC's goal (see Figure 3). However, treatment of more 
latently-infected individuals, for instance, raising r 2 to 20% per year, would 
help reach CDC's target of 1/1,000,000 in a more reasonable period of time 
(see Figure 3). Figure 4 illustrates the effect of HIV on the control of TB. It 
delays the achievement of CDC's goal but has no permanent impact on the 
( 0(0(6 \ I~t=~·SIIl zt ~· O.t 
( 0(0(5 ~ \ 5Xl.O-i \ \ 4XLf' ( 0(0(4: \ 
\ 3Xl.O_, \ ( 0(0(3: ., 
" ( 0(0(t: 
'" 
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Figure 3: Left: r 2 = 5%, no CDC 'TB elimination' by 2020. Right: r 2 = 20%, 
CDC 'TB elimination' by 2020. 
long-term persistence of TB. However, prolonging TB 'survival' enhances the 
likelihood of its evolution, a situation that is not explored here. We present 
two tables in the Appendix with a forecast of the number of new cases and 
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Figure 4: Impact of HIV. Lower curve represents no HIV effect; upper curve 
represents the case rate when HIV is included; both are the same before 1983. 
Dots represents real data 
the number of latently-infected individuals in the U.S. over the next half 
century. 
In this paper we have introduced the impact of HIV I AIDS on TB pro-
gression during the past two decades via the introduction of a temporary 
perturbation on the distribution of TB progression times. Our selection of 
this perturbation is driven by our desire to fit active-TB data since our pri-
mary goal is not to look at the coevolution of co-infections but rather at 
the impact of HIV I AIDS co-infections on the ability of the U.S. to meet 
CDC's target by 2010. Our model suggests that if emphasis is placed on 
treating at least 20% of the latently-infected individuals then CDC's target 
may be met by 2020. Our model also shows that re-emergence of diseases 
that compromise the immune system (or recurrent outbreaks) would make it 
very difficult to control TB unless treatment emphasis is put on the earlier 
(non-detectable) stages of TB diseases. 
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A Tables 
Prediction of TB Incidence of the U.S. 
Year Tuberculosis Year Tuberculosis 
2001 26888.2 2026 6448.9 
2002 25441.8 2027 6121.3 
2003 24039.4 2028 5812.7 
2004 22690. 2029 5522.3 
2005 21397.3 2030 5248.7 
2006 20166.6 2031 4990.4 
2007 19000.6 2032 4746.3 
2008 17895.9 2033 4516.0 
2009 16855.7 2034 4298.4 
2010 15877.9 2035 4092.1 
2011 14959.4 2036 3896.3 
2012 14097.3 2037 3710.9 
2013 13287.8 2038 3535.6 
2014 12530.3 2039 3369.5 
2015 11822.2 2040 3211.6 
2016 11158.8 2041 3061.7 
2017 10538.3 2042 2919.6 
2018 9957.7 2043 2784.4 
2019 9414.6 2044 2655.8 
2020 8905.6 2045 2533.7 
2021 8427.4 2046 2417.7 
2022 7979.6 2047 2307.2 
2023 7559.8 2048 2202.1 
2024 7166.2 2049 2101.9 
2025 6796.8 2040 2006.3 
Table 1: Number of active tuberculosis in the U.S. form 2001 through 2040 
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Prediction of Latent TB of the U.S. 
Year Latent TB Year Latent TB 
2001 1.998606832907533*10° 2026 708910.7866496837 
2002 1.923641943171843*10° 2027 678360.6672065898 
2003 1.851032791472061*10° 2028 64904 7. 8934275835 
2004 1.780727957000281*10° 2029 620964.6129269843 
2005 1.712427328121379*106 2030 594084.6524858062 
2006 1.646274943502753*106 2031 568292.6894604814 
2007 1.582269278290167*10° 2032 543565.8952388513 
2008 1.520080645340529*10° 2033 519911.7440658233 
2009 1.459989683998999*10° 2034 49727 4.2113372126 
2010 1.401935871794004*106 2035 475552.3255516171 
2011 1.345776986524634*106 2036 454698.1230445390 
2012 1.291474406687125*106 2037 434 7 41.4368790902 
2013 1.238867122849632*10° 2038 415693.3226847585 
2014 1.188156782532186*106 2039 397479.3322123775 
2015 1.139338047317955*106 2040 380007.3759705960 
2016 1.092198664367019*10° 2041 363303.6546871724 
2017 1.046814234224803*106 2042 347346.0655184661 
2018 1.003127238758086*106 2043 332053.1078910177 
2019 961123.3758838332 2044 317428.7300328113 
2020 920677.5518493373 2045 303457.5335038745 
2021 881654.2212026586 2046 290103.9100908917 
2022 844202.9677817885 2047 277334.0112790820 
2023 808252.6039557089 2048 265124.3304444849 
2024 773771.6760658747 2049 253436.1904742842 
2025 740708.6360752575 2050 242238.6155298132 
Table 2: Number of Latent TB from 2001 though 2050 
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B Proof of theorem 
Proof. We will use the following facts which are straightforward in real anal-
ysis. 
limsup(A +B) =limA+ limsupB, whenever limA exists 
liminf(A +B) =limA+ liminf B, whenever limA exists 
lim sup ( AB) =lim A lim sup B, whenever lim A exists 
liminf(AB) =limAliminf B, whenever limA exists 
The proof is based on the Fluctuation Theorem (Hirsch, Hanisch and 
Gabriel, 1985) and its extension by Thieme (see Theorem 2.3 in Thieme 
1993). Applying Theorem 2.3 from Thieme to Equations (5) and (6) directly, 
one obtains that 0 :::; /3100 - (J.loo + k + r2)L00 and kL00 :::; (J.loo + d00 + 
rr)/00 • Hence, it follows that /31 00 2:: J.L=+;+r2 (J.loo + doo + rr)/00 , that is, 
] 00 (k+ k + +~ + - 1) = I 00 (Roo - 1) 2:: 0. Since Roo < 1 and I(t) is J.Loo T2 J.Loo oo Tl 
bounded, it follows that ! 00 = 0. A similar argument results in L 00 = 0. 
The first part of this theorem is proved. It is not difficult to show that 
limsupL(t) = 0 if and only if limsupJ(t) = 0. For instance, the fact that 
t-+oo t-+oo 
lim supJ(t) = 0 =?lim supL(t) = 0 is verified below. From Equation (5) 
t-+oo t-+oo 
dL dt :::; f]I- (J.£(t) + k + r 2)L. 
It follows from the comparison principle that 
Lo + rt f]I(s)ef;(J.L(r)+k+r2)dr ds 
L(t) < Jo 
- ef~(J.L(r)+k+r2)dr 
Hence 
f]J ( t )ef~(J.L(r)+k+r2)dr 
limsupL(t) < limsup t 
t-+oo - t-tOO (J.£(t) + k + r2 )efo(J.L(r)+k+r2)dr 
= lim sup j3I(t) = 0. 
t-+oo J-t(t) + k + r2 
20 
The same argument gives limsupL(t) = 0 ==? limsupi(t) = 0. 
t-+oo t-+oo 
Case 1: If kL(t) ~ (J-l(t) + k + r2)I(t) holds for all t > 0, then ~! > 0 
directly implies limsupi(t) > 0; 
t-+oo 
Case 2: If kL(t) < (J-l(t) + k + r2)I(t) holds for all t > 0, then 
limsupi(t) > 0. 
t-+00 
The proof of Case 2 is as follows: Suppose limsupi(t) = 0, then 
t-+oo 
dL > f3 I(t) (N(t) _ J-l(t) + d(t) + r1 I_ I) _ (J-l(t) + d(t) + r1)(J-l(t) + k + r 2 ) I 
dt - N(t) k k 
= (!3 _ (J-l(t) + d(t) + r~(J-l(t) + k + r 2)) I+ o(I2) 
~ (/3- (J-loo + doo) + r~(J-loo + k + r2)) I+ o(I2) 
= (J-loo + doo) + r~(J-loo + k + r2) (Roo- 1)I + o(I2) > 0, fort>> 1. 
This implies that limsupL(t) > 0 which contradicts the assumption 
t-+oo 
limsupi(t) = 0. 
t-+00 
Trajectories of System (5-6) cannot intercept kL(t) = (J-l(t)+d(t)+ri)I(t) 
infinitely many times if I(t) ~ 0 as t ~ oo because ~f > 0 on kL(t) = 
(J-l(t) + d(t) + ri)I(t) whenever R00 > 1. Therefore, limsupi(t) = 0 implies 
t-+oo 
that either kL(t) > (J-l(t) + d(t) + r1)I(t) or kL(t) :s; (J-l(t) + d(t) + r1)I(t) 
holds eventually. Hence, limsupi(t) > 0. D 
f-+00 
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